Nifty Pharma outperforms as US policy shifts ease pressure on Indian drugmakers. Quant MF’s Founder & CIO Sandeep Tandon, stays bullish on generics and CDMOs.
Nifty Pharma outperforms as US policy shifts ease pressure on Indian drugmakers. Quant MF’s Founder & CIO Sandeep Tandon, stays bullish on generics and CDMOs.